Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Clobetasol Propionate

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT03926299Not ApplicableCompletedPrimary

Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus

NCT05125458Completed

Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases.

Showing all 2 trials

Research Network

Common Treatments

  • Clobetasol Propionate1
  • Fotonasmooth Sp Spectro Laser Device1

Active Sponsors

  • University of Campania Luigi Vanvitelli1
  • Prof. Dr. Volker Viereck1

Top Investigators

Related Conditions

  • Hiv1
  • Hbv1
  • Chronic Infectious Disease1
  • Mental Disorders1
  • Hidradenitis Suppurativa1

Activity Timeline